Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor

US Patent 10443039 · Granted Oct 15, 2019

Assignee

Inventors

View full patent text on Google Patents →